Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Campbell, B. J.
Right arrow Articles by Rhodes, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, B. J.
Right arrow Articles by Rhodes, J. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, 2001, Vol. 11, No. 5 385-393
© 2001 Oxford University Press

Increasing the intra-Golgi pH of cultured LS174T goblet-differentiated cells mimics the decreased mucin sulfation and increased Thomsen-Friedenreich antigen (Galß1-3GalNac{alpha}-) expression seen in colon cancer

Barry J. Campbell1, Gillian E. Rowe, Keith Leiper and Jonathan M. Rhodes

Glycobiology Group, Gastroenterology Research Unit, Department of Medicine, University of Liverpool, Daulby Street, Liverpool, L69 3GA, UK

Mucins in ulcerative colitis and colon cancer share common properties of reduced sulfation and increased oncofetal carbohydrate antigen expression. It has previously been shown that there is no simple correlation between these changes and the activity of the relevant glycosyl-, sialyl-, and sulfo-transferases. We examined mucin sulfation and expression of oncofetal Thomsen-Friedenreich (TF) antigen (galactosylß1-3N-acetylgalactosamine{alpha}-) in the goblet cell–differentiated human colon cancer cell line LS174T following treatment with bafilomycin A1, which raises intra-Golgi pH, or monensin, which disrupts medial-trans Golgi transport.

Cells were dual-labeled with sodium [35S]-sulfate and D-[6-3H(N)]-glucosamine hydrochloride, or labeled with L-[U-14C]-threonine alone. Mucin was purified using Sepharose CL-4B gel filtration. Mucin sulfo-Lewisa and TF antigen expression were assessed using the F2 anti-sulfo-Lewisa monoclonal antibody and peanut agglutinin binding respectively.

Bafilomycin (0.01 µM; 48 h) reduced total mucin sulfation, expressed relative to incorporation of glucosamine, to 0.50 ± 0.04 d.p.m. [35S]-sulfate per d.p.m. [3H]-glucosamine compared to control, 0.84 ± 0.05 (p < 0.001, n = 16). This was accompanied by 50.3 ± 8.0% increased expression of TF antigen (p < 0.01) and 50.1 ± 5.5% decreased expression of sulfo-Lewisa (p < 0.01). The reduced sulfate:glucosamine ratio was largely due to increased incorporation of glucosamine into newly synthesized mucin rather than reduction in total sulfate incorporation. In contrast, monensin only reduced total mucin glycosylation at concentrations > 0.1µM and had no significant effect on mucin sulfation or TF expression.

Intra-Golgi alkalinization affects mucin glycosylation, resulting in decreased mucin sulfation and increased expression of TF antigen, changes that mimic those seen in cancerous and premalignant human colonic epithelium.

1 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
T. Tralau, S. Vuilleumier, C. Thibault, B. J. Campbell, C. A. Hart, and M. A. Kertesz
Transcriptomic Analysis of the Sulfate Starvation Response of Pseudomonas aeruginosa
J. Bacteriol., October 1, 2007; 189(19): 6743 - 6750.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
K Bodger, J Halfvarson, A R Dodson, F Campbell, S Wilson, R Lee, E Lindberg, G Jarnerot, C Tysk, and J M Rhodes
Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients
Gut, July 1, 2006; 55(7): 973 - 977.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.